Osteopontin in macrophage function

Expert Reviews in Molecular Medicine

Volumn 13, Issue , 2011, Pages

  Rittling, Susan R ^a  

^a FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; OSTEOPONTIN; TUMOR NECROSIS FACTOR; CYTOKINE;

ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; CELL COUNT; CELL DIFFERENTIATION; CELL KILLING; CELL LINEAGE; CELL MIGRATION; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLOGY; GRANULOMA; HUMAN; IN VITRO STUDY; KIDNEY DISEASE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MONOCYTE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PENICILLIUM MARNEFFEI; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL; ANIMAL; BIOLOGICAL MODEL; GENETICS; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; MACROPHAGES; MICE; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE TYPE II; OSTEOPONTIN;

EID: 79956157867     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399411001839     Document Type: Article

References (153)

1. Senger, D.R. et al. (1989) Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochimica Biophysica Acta 966, 43-48 (Pubitemid 19152726)
2. Oldberg, A., Franzen, A. and Heinegard, D. (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proceedings of the National Academy of Sciences of the United States of America 83, 8819-8823 (Pubitemid 17223492)
3. Brown, L.F. et al. (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Molecular Biology of the Cell 3, 1169-1180 (Pubitemid 23088966)
4. Rittling, S.R. et al. (2003) Osteopontin, a surprisingly flexible cytokine: functions revealed from knockout mice. In Contemporary Immunology: Cytokine Knockouts (2nd edn) (Fantuzzi, G., ed.), pp. 379-393, Humana Press Inc., Totowa, NJ
5. Weber, G.F. and Cantor,H. (1996) The immunology of Eta-1/osteopontin. Cytokine and Growth Factor Reviews 7, 241-248
6. Rittling, S.R. and Chambers, A.F. (2004) Role of osteopontin in tumour progression. British Journal of Cancer 90, 1877-1881 (Pubitemid 38746324)
7. Ramaiah, S.K. and Rittling, S. (2007) Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Expert Opinion on Drug Metabolism and Toxicology 3, 519-526 (Pubitemid 351324961)
8. Giachelli, C. (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthodontics and Craniofacial Research 8, 229-231
9. Scatena, M., Liaw, L. and Giachelli, C.M. (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 27, 2302-2309 (Pubitemid 350203943)
10. Christensen, B. et al. (2007) Cell type-specific posttranslational modifications of mouse osteopontin are associated with different adhesive properties. Journal of Biological Chemistry 282, 19463-19472 (Pubitemid 47100061)
11. Cao, Z. et al. (2008) A novel functional motif of osteopontin for human lymphocyte migration and survival. Molecular Immunology 45, 3683-3692
12. Zheng, W. et al. (2009) Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis and Rheumatism 60, 1957-1965
13. Hu, D.D. et al. (1995) A biochemical characterization of the binding of osteopontin to integrins αvβ1 and αvβ5. Journal of Biological Chemistry 270, 26232-26238
14. Hu, D.D., Hoyer, J.R. and Smith, J.W. (1995) Calcium suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin αvβ3. Journal of Biological Chemistry 270, 9917-9925
15. Bayless, K.J. et al. (1998) Osteopontin is a ligand for the α4β1 integrin. Journal of Cell Science 111, 1165-1174
16. Barry, S.T. et al. (2000) Analysis of the alpha4beta1 integrin-osteopontin interaction. Experimental Cell Research 258, 342-351
17. Yokosaki, Y. et al. (1999) The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. Journal of Biological Chemistry 274, 36328-36334
18. Barry, S.T. et al. (2000) A regulated interaction between alpha5beta1 integrin and osteopontin. Biochemical and Biophysical Research Communications 267, 764-769 (Pubitemid 30099398)
19. Yokosaki, Y. et al. (2005) Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biology 24, 418-427 (Pubitemid 41765020)
20. Denda, S., Reichardt, L.F. and Müller, U. (1998) Identification of osteopontin as a novel ligand for the integrin α8β1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Molecular Biology of the Cell 9, 1425-1435 (Pubitemid 28303487)
21. Schack, L. et al. (2009) Osteopontin enhances phagocytosis through a novel osteopontin receptor, the {alpha}X{beta}2 integrin. Journal of Immunology 182, 6943-6950
22. Weber, G.F. et al. (1996) Receptor-ligand interaction between CD44 and osteopontin (ETA-1). Science 271, 509-512 (Pubitemid 26044470)
23. Smith, L.L. et al. (1999) CD44 is not an adhesive receptor for osteopontin. Journal of Cellular Biochemistry 73, 20-30 (Pubitemid 29115475)
24. Katagiri, Y.U. et al. (1999) CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Research 59, 219-226 (Pubitemid 29062981)
25. Weber, G.F. et al. (2002) Phosphorylationdependent interaction of osteopontin with its receptors regulates macrophage migration and activation. Journal of Leukocyte Biology 72, 752-761 (Pubitemid 36277847)
26. Jain, A. et al. (2002) Three SIBLINGs (SmallIntegrin- Binding LIgand, N-linked Glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. Journal of Biological Chemistry 277, 13700-13708 (Pubitemid 34967971)
27. Rittling, S.R. et al. (2002) Tumor-derived osteopontin is soluble, not matrix associated. Journal of Biological Chemistry 277, 9175-9182 (Pubitemid 34952996)
28. Christensen, B. et al. (2010) Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. Journal of Biological Chemistry 285, 7929-7937
29. Agnihotri, R. et al. (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). Journal of Biological Chemistry 276, 28261-28267
30. Sharif, S.A. et al. (2009) Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis and Rheumatism 60, 2902-2912
31. Zohar, R. et al. (2000) Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. Journal of Cellular Physiology 184, 118-130 (Pubitemid 30349635)
32. Zhu, B. et al. (2004) Osteopontin modulates CD44- dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. Journal of Cellular Physiology 198, 155-167 (Pubitemid 38120976)
33. Cantor, H. and Shinohara, M.L. (2009) Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nature Reviews. Immunology 9, 137-141
34. Inoue, M. et al. (2010) Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses. Journal of Immunology 186, 19-23
35. Rittling, S.R. et al. (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. Journal of Bone amd Mineral Research 13, 1101-1111 (Pubitemid 28311778)
36. Liaw, L. et al. (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). Journal of Clinical Investigation 101, 1468-1478 (Pubitemid 28166845)
37. Lund, S., Giachelli, C. and Scatena, M. (2009) The role of osteopontin in inflammatory processes. Journal of Cell Communication and Signaling 3, 311-322
38. Wang, K.X. and Denhardt, D.T. (2008) Osteopontin: role in immune regulation and stress responses. Cytokine and Growth Factor Reviews 19, 333-345
39. Buback, F. et al. (2009) Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Experimental Dermatology 18, 750-759
40. Bellahcene, A. et al. (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.Nature Reviews. Cancer 8, 212-226 (Pubitemid 351301854)
41. Atkins, K. et al. (1998) Coordinate expression of OPN and associated receptors during monocyte/ macrophage differentiation of HL-60 cells. Journal of Cellular Physiology 175, 229-237 (Pubitemid 28140680)
42. Oyama, Y. et al. (2002) PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells. Circulation Research 90, 348-355 (Pubitemid 34633937)
43. Suzuki, H. et al. (2009) The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nature Genetics 41, 553-562
44. Atkins, K.B., Simpson, R.U. and Somerman, M.J. (1997) Stimulation of osteopontin mRNA expression in HL-60 cells is independent of differentiation. Archives of Biochemistry and Biophysics 343, 157-163 (Pubitemid 27297576)
45. Nakamachi, T. et al. (2007) PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 56, 1662-1670 (Pubitemid 46842601)
46. Li, X., O'Regan, A.W. and Berman, J.S. (2003) IFNgamma induction of osteopontin expression in human monocytoid cells. Journal of Interferon and Cytokine Research 23, 259-265 (Pubitemid 36606458)
47. Miyazaki, Y. et al. (1995) Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene. Annals of the New York Academy of Sciences 760, 334-341
48. Wuthrich, R.P. et al. (1998) Enhanced osteopontin expression and macrophage infiltration in MRLFas( lpr) mice with lupus nephritis. Autoimmunity 28, 139-150 (Pubitemid 29027564)
49. Konno, S. et al. (2006) Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression inhumanmonocytes and dendritic cells. Journal of Interferon and Cytokine Research 26, 562-567 (Pubitemid 44289898)
50. Samuvel, D.J. et al. (2010) Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6- mediated mechanism. Journal of Biological Chemistry 285, 3916-3927
51. Rollo, E.E. and Denhardt, D.T. (1996) Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology 88, 642-647 (Pubitemid 26255138)
52. Solinas, G. et al. (2010) Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for m2-polarization, influencing tumor cell motility. Journal of Immunology 185, 642-652
53. Ogawa, D. et al. (2005) Liver X receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circulation Research 96, e59-e67
54. Guo, H. et al. (2001) Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. Journal of Immunology 166, 1079-1086 (Pubitemid 32060266)
55. Gao, C. et al. (2004) S-nitrosylation of heterogeneous nuclear ribonucleoprotein A/B regulates osteopontin transcription in endotoxinstimulated murine macrophages. Journal of Biological Chemistry 279, 11236-11243 (Pubitemid 38401619)
56. Takahashi, F. et al. (2000) Osteopontin is induced by nitric oxide in RAW 264.7 cells. IUBMB Life 49, 217-221 (Pubitemid 30350869)
57. Gao, C. et al. (2005) Transcriptional regulatory functions of heterogeneous nuclear ribonucleoprotein-U and -A/B in endotoxinmediated macrophage expression of osteopontin. Journal of Immunology 175, 523-530 (Pubitemid 40884358)
58. Zhao, W. et al. (2010) Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists. Journal of Biological Chemistry 285, 20452-20461
59. Nares, S. et al. (2009) Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic porphyromonas gingivalis. American Journal of Pathology 174, 1400-1414
60. Koguchi, Y. et al. (2002) Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells. Infection and Immunity 70, 1042-1048 (Pubitemid 34163372)
61. Khajoee, V. et al. (2006) Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection. Clinical and Experimental Immunology 143, 260-268
62. Wang, Y. et al. (2000) Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. Journal of Gastroenterology 35, 696-701
63. Ragno, S. et al. (2001) Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 104, 99-108
64. van der Windt, G.J. et al. (2009) Osteopontin is not crucial to protective immunity during murine tuberculosis. Immunology 128, e766-e776
65. Kohan, M. et al. (2007) Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clinical and Experimental Allergy 37, 1444-1454 (Pubitemid 47460229)
66. Prasse, A. et al. (2009) Essential role of osteopontin in smoking-related interstitial lung diseases. American Journal of Pathology 174, 1683-1691
67. Nomiyama, T. et al. (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. Journal of Clinical Investigation 117, 2877-2888 (Pubitemid 47529618)
68. Kiefer, F.W. et al. (2008) Osteopontin expression in human and murine obesity: extensive local upregulation in adipose tissue but minimal systemic alterations. Endocrinology 149, 1350-1357 (Pubitemid 351397930)
69. Brown, L.F. et al. (1994) Osteopontin expression and distribution in human carcinomas. American Journal of Pathology 145, 610-623 (Pubitemid 24285968)
70. Kim, J. et al. (2006) Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. American Journal of Gastroenterology 101, 2051-2059 (Pubitemid 44337631)
71. O'Brien, E.R. et al. (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arteriosclerosis and Thrombosis 14, 1648-1656
72. Speer, M.Y. et al. (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. Journal of Experimental Medicine 196, 1047-1055 (Pubitemid 35231763)
73. Hirota, S. et al. (1993) Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. American Journal of Pathology 143, 1003-1008
74. Choi, J.S. et al. (2003) Induction and temporal changes of osteopontin mRNA and protein in the brain following systemic lipopolysaccharide injection. Journal of Neuroimmunology 141, 65-73
75. Iczkiewicz, J., Rose, S. and Jenner, P. (2005) Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat. European Journal of Neuroscience 21, 1911-1920 (Pubitemid 40685869)
76. Yan, Y.P. et al. (2009) Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochemistry International 55, 826-832
77. Fu, Y. et al. (2004) Spinal root avulsion-induced upregulation of osteopontin expression in the adult rat spinal cord. Acta Neuropathologica (Berlin) 107, 8-16 (Pubitemid 38088269)
78. Zhao, C. et al. (2008) Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiology of Disease 31, 209-217
79. Harada, K. et al. (2003) Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis. Pathology International 53, 8-17 (Pubitemid 36241200)
80. Murry, C.E. et al. (1994) Macrophages express osteopontin during repair of myocardial necrosis. American Journal of Pathology 145, 1450-1462 (Pubitemid 24378499)
81. Komatsubara, I. et al. (2003) Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. Cardiovascular Pathology 12, 186-194 (Pubitemid 36765492)
82. Szalay, G. et al. (2009) Osteopontin: a fibrosisrelated marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circulation Research 104, 851-859
83. Makiishi-Shimobayashi, C. et al. (2004) Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear. Auris, Nasus, Larynx 31, 3-9 (Pubitemid 38369368)
84. Hikita, S.T. et al. (2006) Osteopontin is proinflammatory in experimental autoimmune uveitis. Investigative Ophthalmology and Visual Science 47, 4435-4443 (Pubitemid 46579370)
85. Bosco, M.C. et al. (2009) The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis. Journal of Rheumatology 36, 1318-1329
86. McKee, M.D. and Nanci, A. (1996) Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: a potential requirement for macrophage adhesion and phagocytosis. Anatomical Record 245, 394-409 (Pubitemid 26000721)
87. Mori, R., Shaw, T.J. and Martin, P. (2008) Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. Journal of Experimental Medicine 205, 43-51 (Pubitemid 351185714)
88. Nakamura, M. et al. (2002) Osteopontin expression in chronic pancreatitis. Pancreas 25, 182-187 (Pubitemid 34815917)
89. Sato, T. et al. (2005) Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 54, 1254-1262 (Pubitemid 41192483)
90. White, F.J. et al. (2006) Secreted phosphoprotein 1 (osteopontin) is expressed by stromal macrophages in cyclic and pregnant endometrium of mice, but is induced by estrogen in luminal epithelium during conceptus attachment for implantation. Reproduction 132, 919-929 (Pubitemid 46040662)
91. Ophascharoensuk, V. et al. (1998) Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney International 54, 416-425 (Pubitemid 28357404)
92. Hudkins, K.L. et al. (2000) Osteopontin expression in human crescentic glomerulonephritis. Kidney International 57, 105-116 (Pubitemid 30227758)
93. Hartner, A. et al. (2001) Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats. American Journal of Kidney Diseases 38, 153-164 (Pubitemid 32611772)
94. Hudkins, K.L. et al. (2001) Osteopontin expression in human cyclosporine toxicity. Kidney International 60, 635-640 (Pubitemid 32678907)
95. Cao, Z., Cox, A. and Bonnet, F. (2002) Increased osteopontin expression following renal ablation is attenuated by angiotensin type 1 receptor antagonism. Experimental Nephrology 10, 19-25
96. Tian, S. et al. (2006) Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colonystimulating factor: implication for the role of atorvastatin. Mediators of Inflammation 2006, 12919
97. Peng, X. et al. (2006) Detection of osteopontin in the pericyst of human hepatic Echinococcus granulosus. Acta Tropica 100, 163-171 (Pubitemid 46176760)
98. Nishikaku, A.S. et al. (2009) Nitric oxide participation in granulomatous response induced by Paracoccidioides brasiliensis infection in mice. Medical Microbiology and Immunology 198, 123-135
99. Smith, L.L. et al. (1998) Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by à 9 á 1 integrin. Journal of Biological Chemistry 271, 28485-28491 (Pubitemid 26374670)
100. Kazanecki, C.C., Uzwiak, D.J. and Denhardt, D.T. (2007) Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. Journal of Cellular Biochemistry 102, 912-924 (Pubitemid 350036931)
101. Prieto, J., Eklund, A. and Patarroyo, M. (1994) Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cellular Immunology 156, 191-211 (Pubitemid 24197252)
102. Ammon, C. et al. (2000) Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100, 364-369 (Pubitemid 30449951)
103. Shima, M. et al. (1995) Macrophage-colonystimulating factor regulates expression of the integrins alpha 4 beta 1 and alpha 5 beta 1 by murine bone marrowmacrophages. Proceedings of the National Academy of Sciences of the United States of America 92, 5179-5183
104. De Nichilo, M.O. and Burns, G.F. (1993) Granulocyte-macrophage and macrophage colonystimulating factors differentially regulate alpha v integrin expression on cultured human macrophages. Proceedings of the National Academy of Sciences of the United States of America 90, 2517-2521 (Pubitemid 23078659)
105. Lacy-Hulbert, A. et al. (2007) Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proceedings of the National Academy of Sciences of the United States of America 104, 15823-15828 (Pubitemid 350035383)
106. Ashkar, S. et al. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860-864 (Pubitemid 30084330)
107. Potter, M.R. et al. (2002) Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi. Infection and Immunity 70, 1372-1381 (Pubitemid 34163414)
108. Isoda, K. et al. (2003) Osteopontin transgenic mice fed a high-cholesterol diet develop early fattystreak lesions. Circulation 107, 679-681 (Pubitemid 36222592)
109. Abel, B. et al. (2005) Osteopontin is not required for the development of Th1 responses and viral immunity. Journal of Immunology 175, 6006-6013 (Pubitemid 41508086)
110. O'Regan, A.W., Hayden, J.M. and Berman, J.S. (2000) Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. Journal of Leukocyte Biology 68, 495-502
111. Zhang, S. andWang, Q. (2008) Factors determining the formation and release of bioactive IL-12: regulatory mechanisms for IL-12p70 synthesis and inhibition. Biochemical and Biophysical Research Communications 372, 509-512
112. Konno, S. et al. (2005) Endotoxin contamination contributes to the in vitro cytokine-inducing activity of osteopontin preparations. Journal of Interferon and Cytokine Research 25, 277-282 (Pubitemid 40664425)
113. Aziz, M. et al. (2009) MFG-E8 attenuates intestinal inflammation in murine experimental colitis by modulating osteopontin-dependent {alpha}v{beta}3 integrin signaling. Journal of Immunology 182, 7222-7232
114. Shimizu, S. et al. (2010) Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages. Arthritis and Rheumatism 62, 1329-1337
115. Naldini, A. et al. (2006) Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontinactivated human monocytes. Journal of Immunology 177, 4267-4270 (Pubitemid 44469753)
116. Patarca, R., Saavedra, R.A. and Cantor, H. (1993) Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early Tlymphocyte activation 1/ osteopontin gene. Critical Reviews in Immunology 13, 225-246 (Pubitemid 2030713)
117. Ono, M., Yamamoto, T. and Nose, M. (1995) Allelic difference in the nucleotide sequence of the Eta-1/ Op gene transcript. Molecular Immunology 32, 447-448
118. Miyazaki, T. et al. (2005) Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. European Journal of Immunology 35, 1510-1520 (Pubitemid 40691432)
119. Gao, C. et al. (2003) Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages. Biochemical and Biophysical Research Communications 309, 120-125 (Pubitemid 36999767)
120. Marroquin, C.E. et al. (2004) Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells. Immunology Letters 95, 109-112 (Pubitemid 39119908)
121. Vaschetto, R. et al. (2008) Serum levels of osteopontin are increased in SIRS and sepsis. Intensive Care Medicine 34, 2176-2184
122. Steitz, S.A. et al. (2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. American Journal of Pathology 161, 2035-2046 (Pubitemid 35434850)
123. Rollo, E.E., Laskin, D.L. and Denhardt, D.T. (1996) Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW 264.7 macrophages. Journal of Leukocyte Biology 60, 397-404 (Pubitemid 26325622)
124. Tian, J.Y. et al. (2000) Regulation of NO synthesis induced by inflammatory mdiators in RAW264.7 cells: collagen prevents inhibition by osteopontin. Cytokine 12, 450-457 (Pubitemid 30449842)
125. Gao, C. et al. (2007) Osteopontin induces ubiquitindependent degradation of STAT1 in RAW264.7 murine macrophages. Journal of Immunology 178, 1870-1881 (Pubitemid 46154660)
126. Guo, H. et al. (2008) Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis. Surgery 144, 182-188
127. Bourassa, B., Monaghan, S. and Rittling, S.R. (2004) Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice. Cellular Immunology 227, 1-11 (Pubitemid 38393724)
128. Heilmann, K. et al. (2009) Osteopontin as two-sided mediator of intestinal inflammation. Journal of Cellular and Molecular Medicine 13, 1162-1174
129. Nau, G.J. et al. (1999) Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infection and Immunity 67, 4223-4230 (Pubitemid 29357049)
130. Pedraza, C.E. et al. (2008) Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing. Bone 43, 708-716
131. Singh, R.P. et al. (1990) Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. Journal of Experimental Medicine 171, 1931-1942 (Pubitemid 20200234)
132. Giachelli, C.M. et al. (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. American Journal of Pathology 152, 353-358 (Pubitemid 28106380)
133. Marcondes, M.C. et al. (2008) In vivo osteopontininduced macrophage accumulation is dependent on CD44 expression. Cellular Immunology 254, 56-62
134. Bruemmer, D. et al. (2003) Angiotensin IIaccelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. Journal of Clinical Investigation 112, 1318-1331 (Pubitemid 38057686)
135. Duvall, C.L. et al. (2008) The role of osteopontin in recovery from hind limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology 28, 290-295 (Pubitemid 351161202)
136. Nystrom, T., Duner, P. and Hultgardh-Nilsson, A. (2007) A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Experimental Cell Research 313, 1149-1160 (Pubitemid 46427814)
137. Panzer, U. et al. (2001) Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney International 59, 1762-1769 (Pubitemid 32336790)
138. Okada, H. et al. (2000) Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. American Journal of Physiology. Renal Physiology 278, F110-F121 (Pubitemid 30106132)
139. Mazzali, M. et al. (2002) Effects of cyclosporine in osteopontin null mice. Kidney International 62, 78-85 (Pubitemid 34754050)
140. Ophascharoensuk, V. et al. (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney International 56, 571-580 (Pubitemid 29353155)
141. Yoo, K.H. et al. (2006) Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney International 70, 1735-1741 (Pubitemid 44684804)
142. Persy, V.P. et al. (2003) Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney International 63, 543-553 (Pubitemid 36126800)
143. Wolak, T. et al. (2009) Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney International 76, 32-43
144. Morimoto, J. et al. (2004) Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms. International Immunology 16, 477-488 (Pubitemid 38313156)
145. O'Regan, A.W. et al. (2001) Abnormal pulmonary granuloma formation in osteopontin-deficient mice. American Journal of Respiratory and Critical Care Medicine 164, 2243-2247
146. Crawford, H.C.,Matrisian, L.M. and Liaw, L. (1998) Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Research 58, 5206-5215 (Pubitemid 28521184)
147. Feng, F. and Rittling, S.R. (2000) Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency. Breast Cancer Research and Treatment 63, 71-79
148. Cheng, J. et al. (2007) Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. Cancer Research 67, 5141-5147 (Pubitemid 46997250)
149. Kiefer, F.W. et al. (2010) Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59, 935-946
150. Kwon, H.J. et al. (2010) The role of osteopontin in dgalactosamine- induced liver injury in genetically obese mice. Toxicology and Applied Pharmacology 242, 344-351
151. da Silva, A.P. et al. (2009) Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Investigation 89, 1169-1181
152. da Silva, A.P. et al. (2006) Exacerbated tissue destruction in
153. Zhong, J. et al. (2006) Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis. Inflammatory Bowel Diseases 12, 790-796 (Pubitemid 44253763)